The largest database of trusted experimental protocols

33 protocols using monensin golgi stop

1

PMA and Ionomycin Stimulation of Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 × 106 cells were stimulated for 4 h at 23°C with 40 ng ml−1 PMA and 1 μg ml−1 ionomycin in the presence of 2 μM Monensin (Golgi-Stop, BD Biosciences, Cat: 51–2092KZ). Cells were washed twice with FACS buffer and stained for extracellular markers, fixed/permeabilized and stained for intracellular markers as described above.
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of Cytokine Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated splenocytes (1 × 106 cells/well) were stimulated for 1 h with 5 µg/ml MOMP in the presence of 1 µg/ml anti-CD28 and anti-CD49d mAbs (both BD Pharmingen, San Diego, CA, USA) in a total volume of 200 µl supplemented with RPMI 1640. The cells were subsequently incubated for 5 h at 37℃ after addition of 10 µg/ml brefeldin A (Sigma Aldrich) and 0.7 µl/ml monensin/Golgi-stop (BD Pharmingen). Following overnight storage at 4℃, the cells were washed in FACS buffer and stained with anti-CD4 (APC) and anti-CD44 (FITC) mAbs (BD Biosciences) in FACS buffer for 30 min at 4℃. Cells were washed with FACS buffer, permeabilized by using the Cyto-fix/Cyto-perm kit (BD Pharmingen) according to the manufacturer’s instructions, and stained intracellularly for 30 min at 4℃ using anti-IFN-γ (PE–Cy7) and anti-IL-17a (PerCP–Cy5.5) mAbs (eBiosciences, San Diego, CA, USA) in Perm wash buffer. After washing, the cells were re-suspended in FACS buffer and analysed by flow cytometry using a six-colour BD FACS Canto flow cytometer (BD Biosciences). Responses were analysed with the FlowJo software (Tree Star Inc., Ashland, OR, USA).
+ Open protocol
+ Expand
3

Peptide-pulsed CD4+ T Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptide-pulsed autologous CD4+ T cells were used as antigen presenting cells (APC) for stimulation assays. APC were labeled with 5μM CellTrace Violet (CTV) as recommended by the manufacturer (Life Technologies, Carlsbad, CA) and pulsed with the Gag peptide for 30 m at room temperature and washed D-PBS and then resuspended in T-cell medium. 1 × 106 CD4+ T cells or T-cell clones were co-cultured with an equal amount of pulsed or unpulsed APC for 6 h with monensin (Golgi stop; BD Biosciences) and anti-human CD107a (H4A3; BD Biosciences). Cells were surface stained, fixed and permeabilized with Cytofix/Cytoperm solution (BD Biosciences) and stained for IFN-γ (#B27) and MIP1-β (# D21-1351) both from BD Biosciences.
+ Open protocol
+ Expand
4

Flow Cytometry Analysis of Splenocyte Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Based our protocol from previous publication (16 ), we resuspended the splenocytes from the immunized in 10μl of RPMI-1640 media. The cells were ex vivo stimulated with anti-CD107a antibody (BD Biosciences, 553792), anti-CD28/CD49d antibody (BD Biosciences, 347690) and OLP or DMSO in 10μl. The mixture was incubated in 5% CO2, 37°C incubator for 1hour and treated with 4μl of mixture of the complete RPMI-1640 media: Brefeldin A (GolgiPlug, BD Biosciences, 555029):Monensin (GolgiStop, BD Biosciences, 554715) in 55:3:2. After 12hours of incubation in 5% CO2, 37°C, the cells were washed with PBS and stained with surface antibodies (anti-CD44 BV421 [BD Biosciences, 536970], anti-CD8a BV510 [BD Biosciences, 563068], anti-CD62L BV650 [BD Biosciences, 564108], anti-CD3 BV786 [BD Biosciences, 564010], anti-CD4 PerCP-Cy5.5 [BD Biosciences, 561115], and anti-CD19 APC [BD Biosciences, 561738]) for 15 minutes at RT and washed. Cells were then fixed with 4% paraformaldehyde in PBS and permeabilized. We then washed the cells and stained with FACS antibodies (anti-IL-2 FITC [BD Biosciences, 562040], anti-TNF PE [BD Biosciences, 554419], anti-IFN-γ [BD Biosciences, 557735], and anti-CD107a [BD Biosciences, 560647]) by 20 minutes of incubation at room temperature, washed twice with the permeabilization buffer and resuspended with 300μl of PBS.
+ Open protocol
+ Expand
5

Splenocyte Activation Assay for H37Rv CSA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes isolated from randomly selected mice in different groups were isolated as described above and 2X106 splenocytes per well were cultured in RPMI 1640 (Gibco, Invitrogen, UK) containing 10% FBS in a 12-well plate (Nunc, USA) at 37°C in 5% CO2 for 4 hours to bring the cellular activity to basal levels. Splenocytes were then challenged with 20 μg/ml of H37Rv CSA and cultured for an additional 2 hours, after which 5 μl Monensin (Golgi-Stop, BD Biosciences) and 5 μl of anti-CD107A-FITC antibody (BD Biosciences) were added per well and cultured for an additional 4 hours at 37°C in 5% CO2. These cells were then collected and surface-stained for FACS analysis.
+ Open protocol
+ Expand
6

PBMC Activation and Cytokine Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated from heparin blood by density gradient centrifugation (Ficoll-Hypaque, PLUS Healthcare, Buckinghamshire, UK). PBMCs were washed twice with PBS, resuspended in complete media and stimulated in sterile polystyrene round bottom tubes (Falcon; BD Biosciences). Each tube contained 106 PBMC, anti-CD107a antibody (BD Biosciences), Monensin (‘Golgistop’, BD Biosciences), one of the stimulants (SEB, one of 16 different PepMix solutions, or tuberculin) plus complete media to a final volume of 250 μl. Stimulations were incubated at 37 °C in 5% CO2, humidified atmosphere, for 2 h prior to the addition of 250 μl Brefeldin A (BFA, final concentration 10 μg/ml; Sigma-Aldrich). Incubation was stopped after an additional 14 h.
+ Open protocol
+ Expand
7

Cytokine profiling of T-cell response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymph node cells were stimulated with 2 µg/ml H56 together with anti-CD28 (37.51; BD Biosciences) and anti-CD49d (9C10; BD Biosciences) for 1 h. Subsequently, 10 µg/well brefeldin A (Sigma-Aldrich, St. Louis, MO) and 0.7 µl/well monensin/GolgiStop (BD Biosciences Franklin Lakes, NJ) were added and cells were incubated for 5 h at 37 °C. After overnight storage at 4 °C, cells were washed in FACS buffer (1% FCS (VWR-Bie & Berntsen, Herlev, Denmark), 0.1% sodium azide (VWR, Radnor, PA) in PBS (Life Technologies, Carlsbad, CA), and stained for surface markers with 1 µg/ml anti-CD4-APC-eFlour780 (clone GK1.5) and 1 µg/ml anti-CD44-FITC (clone IM7) (both eBiosciences, San Diego, CA) for 30 min at 4 °C. Cells were washed with FACS buffer, before fixation and permeabilization using Cytofix/Cytoperm kit (BD Biosciences Franklin Lakes, NJ). Subsequently, cells were stained for intracellular cytokines with 1 µg/ml anti-IFN-γ PE-Cy7 (XMG1.2; eBiosciences, San Diego, CA), 1 µg/ml anti-TNF-PE (MP6-XT22; eBiosciences, San Diego, CA) and 1 µg/ml IL-17A for 20 min. Finally, cells were washed, re-suspended in FACS buffer, and analyzed using a FACSCanto flow cytometer (BD Biosciences Franklin Lakes, NJ) and FlowJo software version 10.
+ Open protocol
+ Expand
8

Quantifying Tumor-Specific T Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were made from spleens of treated mice and red cells were lysed with ammonium-chloride-potassium buffer (Quality Biological, Gaithersburg, MD). Splenocytes were cocultured with 1 × 106 irradiated A20 cells or 4T1 cells (irrelevant cell line) for 24 h at 37 °C and 5% CO2 in the presence of 0.5 μg/ml anti-mouse CD28 mAb. αCD28 and αCD3 (0.05 μg/ml) without tumor cells served as a positive control. Monensin (GolgiStop; BD Biosciences, San Jose, CA) and brefeldin A (eBioscience, San Diego, CA) were added for the last 6 h. Intracellular IFN-γ expression was assessed using BD Cytofix/Cytoperm Plus Kit, staining with αCD4, αCD8a, and αIFN-γ and analyzed by flow cytometry.
+ Open protocol
+ Expand
9

Assessing Cell Viability and CD107a Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess viability, cells were stained with LIVE/DEAD fixable NEAR-IR dead cell stain kit according to manufacturer’s protocol (Life Technologies). To stain CD107a, cell cultures were supplemented with CD107a/FITC mAb (or control IgG1/FITC) for 6 h, with the addition of monensin (Golgi stop, diluted 1:1500; BD Pharmingen) and 10 μg/ml Brefeldin A (Sigma-Aldrich) after the first hour. The cell-surface and intracellular staining procedures were performed as described previously14 (link). Immunolabeled cells resuspended in 1% paraformaldehyde (PFA) were acquired on a FACSCanto II (BD Biosciences) or Cytoflex (Beckman Coulter). Positive cell gating was set using fluorescence minus one control (FMO). Mean fluorescence intensity (MFI) was subtracted of the value obtained with isotype control antibody. Data analyses were performed using FlowJo software (TreeStar).
+ Open protocol
+ Expand
10

Isolation and Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single‐cell suspensions from spleen, mesenteric lymph nodes and liver were isolated in phosphate‐buffered saline (PBS) containing 1% foetal bovine serum as described previously.12 For CXCL12+ Tfh cell analysis, cells were stimulated for 6 hours in culture medium containing phorbol myristate acetate (PMA, 25 ng/mL; Sigma‐Aldrich), ionomycin (1 μg/mL; Sigma‐Aldrich) and monensin (Golgi Stop; 1 μg/mL; BD Biosciences). Cells then were incubated for 30 minutes at 4°C with the following monoclonal antibodies: CD3e‐Percp‐cy5.5 (clone 145‐2C11, eBioscience), CD4‐PE‐Cy7 (clone GK1.5, eBioscience), PD‐1‐PE (clone J42, eBioscience) and CXCR5‐FITC (clone 2G8, BD Pharmingen). After staining of surface markers, the cells were permeabilized with cold Fix/Perm Buffer, and incubated with CXCL12‐APC (clone 79018, R&D Systems) after blockade with antimouse CD16/32 (clone 93, eBioscience). For eosinophil surface marker analysis, cells were incubated with Siglec‐F‐PE (clone E50‐2440, BD Pharmingen), CXCR4‐FITC (clone 2B11/CXCR4, BD Pharmingen) or isotype (BD Pharmingen) antibodies. Cells acquisition was performed using a FACSVerse cytometer (Lasers: 488 and 633; Mirrors: 507 LP, 560 LP, 665 LP, 752 LP, 660/10, and 752 LP; Filters: 488/15, 527/32, 568/42, 700/54, 783/56, 660/10 and 783/56, BD Biosciences). Data were analysed with FlowJo (Tree Star, version 10.0.7).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!